C07K 2319/80
Containing a dna binding domain
Official title: containing a DNA binding domain, e.g. Lacl or Tet-repressor
C07K2319/80 (Containing a dna binding domain) appears on 946 US grants and 1,666 published applications in this corpus.
Search patents in C07K- Granted patents
- 946
- Published applications
- 1,666
- Assignees
- 552
- Inventors
- 2,601
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 9 | 0 |
| 1994 | 4 | 0 |
| 1995 | 5 | 0 |
| 1996 | 13 | 0 |
| 1997 | 25 | 0 |
| 1998 | 22 | 0 |
| 1999 | 26 | 0 |
| 2000 | 21 | 0 |
| 2001 | 16 | 1 |
| 2002 | 9 | 21 |
| 2003 | 11 | 29 |
| 2004 | 5 | 18 |
| 2005 | 10 | 17 |
| 2006 | 9 | 29 |
| 2007 | 13 | 13 |
| 2008 | 3 | 18 |
| 2009 | 4 | 18 |
| 2010 | 14 | 26 |
| 2011 | 13 | 43 |
| 2012 | 14 | 45 |
| 2013 | 26 | 43 |
| 2014 | 31 | 57 |
| 2015 | 33 | 76 |
| 2016 | 54 | 82 |
| 2017 | 42 | 69 |
| 2018 | 41 | 83 |
| 2019 | 49 | 77 |
| 2020 | 66 | 101 |
| 2021 | 58 | 109 |
| 2022 | 52 | 118 |
| 2023 | 56 | 121 |
| 2024 | 61 | 143 |
| 2025 | 67 | 170 |
| 2026 | 58 | 139 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Non-viral transcription activation domains and methods and uses related thereto6 Oct 2026US 12,753,212 B2Teknologian tutkimuskeskus VTT Oy
- Prime editor system for in vivo genome editing6 Oct 2026US 12,753,397 B2University of Massachusetts
- Pharmaceutical composition for treatment or prevention of ischemic cardiovascular disease29 Sep 2026US 12,746,220 B2Industry-Academic Cooperation Foundation, Yonsei University
- HTT repressors comprising a zinc-finger protein transcription factor29 Sep 2026US 12,747,273 B2Sangamo Therapeutics, Inc.
- Targeting MYD88 gene in vitro and in vivo8 Sep 2026US 12,729,224 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Epigenetic repression protein therapy for rasopathies8 Oct 2026US 2026/0306675 A1Battelle Memorial Institute
- Novel base editors and uses thereof8 Oct 2026US 2026/0308552 A1Huidagene Therapeutics (Singapore) Pte. Ltd.
- Cas-embedded Cytidine Deaminase Ribonucleoprotein Complexes having Improved Base Editing Specificity and Efficiency8 Oct 2026US 2026/0308553 A1University of Massachusetts
- Fusion proteins comprising cas enzymes and dna-binding proteins8 Oct 2026US 2026/0308557 A1Sarepta Therapeutics, Inc.
- Adenine base editors with reduced off-target effects8 Oct 2026US 2026/0308561 A1President and Fellows of Harvard College
Most cited
By later US patents
- Regulation of endogenous gene expression in cells using zinc finger proteins648US 6,534,261 B1Sangamo BioSciences, Inc. · 2003
- Binding proteins for recognition of DNA434US 6,007,988 AMedical Research Council · 1999
- Binding proteins for recognition of DNA423US 6,013,453 AMedical Research Council · 2000
- Regulation of endogenous gene expression in cells using zinc finger proteins395US 6,824,978 B1Sangamo BioSciences, Inc. · 2004
- Modulation of endogenous gene expression in cells383US 6,933,113 B2Sangamo BioSciences, Inc. · 2005